MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$78 | -$56 | -$30 |
| Dep. & Amort. | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in WC | -$3 | $2 | $2 |
| Other Non-Cash | $1 | $1 | $1 |
| Operating Cash Flow | -$79 | -$52 | -$27 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$125 | $0 | $0 |
| Inv. Sales/Matur. | $45 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$81 | -$0 | -$1 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $120 | $105 | $33 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $0 | $0 |
| Financing Cash Flow | $118 | $105 | $33 |
| Forex Effect | $0 | $0 | $22 |
| Net Chg. in Cash | -$42 | $52 | $28 |
| Supplemental Information | – | – | – |
| Beg. Cash | $80 | $28 | $0 |
| End Cash | $38 | $80 | $28 |
| Free Cash Flow | -$80 | -$52 | -$27 |